Two Sigma Investments, LP Eloxx Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.58 $5,538 - $13,385	-23,079 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.4 - $0.72 $37,860 - $68,148	-94,650 Reduced 80.4%	23,079 $13,000
Q4 2021 Feb 14, 2022	SELL	$0.62 - $1.61 $122,229 - $317,403	-197,145 Reduced 62.61%	117,729 $83,000
Q3 2021 Nov 15, 2021	BUY	$1.22 - $2.0 $254,216 - $416,748	208,374 Added 195.66%	314,874 $513,000
Q2 2021 Aug 16, 2021	BUY	$1.35 - $3.36 $143,775 - $357,840	106,500 New	106,500 $212,000
Q4 2019 Feb 14, 2020	SELL	$3.19 - $7.56 $83,000 - $196,703	-26,019 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.37 - $9.91 $113,703 - $257,848	26,019 New	26,019 $118,000
Q3 2018 Nov 14, 2018	SELL	$11.95 - $19.63 $251,846 - $413,702	-21,075 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$8.75 - $23.27 $184,406 - $490,415	21,075 New	21,075 $360,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.